Clinical Trials Browser

Phase 1/2 × INDUSTRY × Dronabinol × Clear all

NCT05272865 2023-02-01

Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

Phase 1/2 Unknown

Cancer Pain, Neoplasms, Vomiting